A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age
Buckley, Sarah A., Mawad, Raya, Gooley, Ted A., Becker, Pamela S., Sandhu, Vicky, Hendrie, Paul, Scott, Bart L., Wood, Brent L., Walter, Roland B., Smith, Kelly, Dean, Carol, Estey, Elihu H., Pagel, JVolume:
170
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.13437
Date:
August, 2015
File:
PDF, 170 KB
english, 2015